| European guidance for the diagnosis and management of osteoporosis in postmenopausal women |
143 |
| Hip fracture trends in the United States, 2002 to 2015 |
37 |
| Risk of subsequent fracture after prior fracture among older women |
32 |
| Diagnosis and management of bone fragility in diabetes: an emerging challenge |
31 |
| A systematic review of factors affecting medication adherence among patients with osteoporosis |
24 |
| Estrogen therapy for osteoporosis in the modern era |
23 |
| Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures-results from the ICUROS |
21 |
| Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study |
21 |
| Impact of muscle atrophy on bone metabolism and bone strength: implications for muscle-bone crosstalk with aging and disuse |
19 |
| The effect of icariin on bone metabolism and its potential clinical application |
19 |
| Glucocorticoid-induced osteoporosis: 2019 concise clinical review |
18 |
| Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies |
18 |
| Characteristics of recurrent fractures |
18 |
| The relationship between sarcopenia and fragility fracturea systematic review |
17 |
| Benefits and safety of dietary protein for bone health-an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation |
17 |
| Milk and other dairy foods and risk of hip fracture in men and women |
17 |
| Notch in skeletal physiology and disease |
17 |
| Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis |
14 |
| The Forteo Patient Registry linkage to multiple state cancer registries: study design and results from the first 8years |
14 |
| Were VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty sham trials? |
13 |
| Inflammatory cytokines IL-6 and TNF- in patients with hip fracture |
12 |
| Osteoporotic vertebral deformity with endplate/cortex fracture is associated with higher further vertebral fracture risk: the Ms. OS (Hong Kong) study results |
12 |
| Patients with prostate cancer and androgen deprivation therapy have increased risk of fracturesa study from the fractures and fall injuries in the elderly cohort (FRAILCO) |
12 |
| Quality indicators for hip fracture care, a systematic review |
12 |
| Is calcifediol better than cholecalciferol for vitamin D supplementation? |
12 |
| Association of sitting time and breaks in sitting with muscle mass, strength, function, and inflammation in community-dwelling older adults |
12 |
| Association of renal function with bone mineral density and fracture risk in the Longitudinal Aging Study Amsterdam |
11 |
| Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study |
11 |
| Fermented dairy products consumption is associated with attenuated cortical bone loss independently of total calcium, protein, and energy intakes in healthy postmenopausal women |
11 |
| Effect of vitamin K on bone mineral density and fractures in adults: an updated systematic review and meta-analysis of randomised controlled trials |
11 |
| The orthogeriatric comanagement improves clinical outcomes of hip fracture in older adults |
11 |
| Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption |
11 |
| Population-based study of age- and sex-related differences in muscle density and size in thoracic and lumbar spine: the Framingham study |
11 |
| Prediction of incident vertebral fracture using CT-based finite element analysis |
11 |
| Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts' consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation |
11 |
| Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study |
11 |
| Risk factors and score for recollapse of the augmented vertebrae after percutaneous vertebroplasty in osteoporotic vertebral compression fractures |
11 |
| Lean mass and lower limb muscle function in relation to hip strength, geometry and fracture risk indices in community-dwelling older women |
11 |
| Percutaneous vertebroplasty versus non-operative treatment for osteoporotic vertebral compression fractures: a meta-analysis of randomized controlled trials |
10 |
| Comorbidity as the dominant predictor of mortality after hip fracture surgeries |
10 |
| Combination therapy with parathyroid hormone analogs and antiresorptive agents for osteoporosis: a systematic review and meta-analysis of randomized controlled trials |
10 |
| Genome-wide identification of m(6)A-associated SNPs as potential functional variants for bone mineral density |
10 |
| Risk of imminent fracture following a previous fracture in a Swedish database study |
9 |
| Neurological symptoms in Hypophosphatasia |
9 |
| Effects of obesity and diabetes on rate of bone density loss |
9 |
| High dairy protein intake is associated with greater bone strength parameters at the distal radius and tibia in older men: a cross-sectional study |
9 |
| Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies |
9 |
| Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at all |
9 |
| Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature |
9 |
| The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease |
9 |
